XML 26 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
5) Stock-based Compensation
9 Months Ended
Sep. 30, 2018
Notes  
5) Stock-based Compensation

5)      Stock Compensation Plans

 

The Company has four fixed option plans (the “2003 Plan”, the “2006 Director Plan”, the “2013 Plan” and the “2014 Director Plan”). Compensation expense for options issued of $58,691 and $102,429 has been recognized for these plans for the three months ended September 30, 2018 and 2017, respectively, and $174,831 and $305,741 has been recognized for these plans for the nine months ended September 30, 2018 and 2017, respectively. As of September 30, 2018, the total unrecognized compensation expense related to the options issued was $38,915, which is expected to be recognized over the vesting period of one year.

 

The fair value of each option granted is estimated on the date of grant using the Black Scholes Option Pricing Model. The Company estimates the expected life of the options using the simplified method. Future volatility is estimated based upon the weighted historical volatility of the Company’s Class A common stock over a period equal to the expected life of the options. The risk-free interest rate for the expected life of the options is based upon the Federal Reserve Board’s daily interest rates in effect at the time of the grant.

 

A summary of the status of the Company’s stock compensation plans as of September 30, 2018, and the changes during the nine months ended September 30, 2018, are presented below:

 

 

 

Number of Class A Shares

 

Weighted Average Exercise Price

 

Number of Class C Shares

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

        880,426

 

$      4.35

 

        523,603

 

$      5.24

Granted

 

                    -

 

 

 

                    -

 

 

Exercised

 

         (36,133)

 

 

 

                    -

 

 

Cancelled

 

           (5,704)

 

 

 

                    -

 

 

Outstanding at September 30, 2018

 

        838,589

 

$      4.48

 

         523,603

 

$      5.24

 

 

 

 

 

 

 

 

 

As of September 30, 2018:

 

 

 

 

 

 

 

 

Options exercisable

 

         805,902

 

$      4.46

 

         505,227

 

$      5.26

 

 

 

 

 

 

 

 

 

As of September 30, 2018:

 

 

 

 

 

 

 

 

Available options for future grant

 

         421,241

 

 

 

         165,638

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

outstanding at September 30, 2018

 

6.05 years

 

 

 

2.69 years

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

exercisable at September 30, 2018

 

6.05 years

 

 

 

2.45 years

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options

 

 

 

 

 

 

 

 

outstanding at September 30, 2018 (1)

 

$867,356

 

 

 

$267,943

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options

 

 

 

 

 

 

 

 

exercisable at September 30, 2018 (1)

 

$862,157

 

 

 

$260,592

 

 

                                

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) The Company used a stock price of $5.20 as of September 30, 2018 to derive intrinsic value.

 

A summary of the status of the Company’s stock compensation plans as of September 30, 2017, and the changes during the nine months ended September 30, 2017, are presented below:

 

 

 

Number of Class A Shares

 

Weighted Average Exercise Price

 

Number of Class C Shares

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

        741,973

 

$      4.33

 

        556,298

 

$      4.61

Granted

 

                    -

 

 

 

                    -

 

 

Exercised

 

                    -

 

 

 

       (103,402)

 

 

Cancelled

 

                    -

 

 

 

         (24,227)

 

 

Outstanding at September 30, 2017

 

        741,973

 

$      4.33

 

        428,669

 

$      5.59

 

 

 

 

 

 

 

 

 

As of September 30, 2017:

 

 

 

 

 

 

 

 

Options exercisable

 

         706,854

 

$      4.21

 

         407,669

 

$      5.50

 

 

 

 

 

 

 

 

 

As of September 30, 2017:

 

 

 

 

 

 

 

 

Available options for future grant

 

         525,682

 

 

 

         227,750

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

outstanding at September 30, 2017

 

6.62 years

 

 

 

2.63 years

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

exercisable at September 30, 2017

 

6.50 years

 

 

 

2.55 years

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options

 

 

 

 

 

 

 

 

outstanding at September 30, 2017 (1)

 

$941,567

 

 

 

$151,012

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options

 

 

 

 

 

 

 

 

exercisable at September 30, 2017 (1)

 

$941,311

 

 

 

$151,012

 

 

                                

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) The Company used a stock price of $5.10 as of September 30, 2017 to derive intrinsic value.

 

The total intrinsic value (which is the amount by which the fair value of the underlying stock exceeds the exercise price of an option on the exercise date) of stock options exercised during the nine months September 30, 2018 and 2017 was $118,003 and $578,017, respectively.